Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations
- PMID: 10833477
- DOI: 10.1016/s0016-5085(00)70355-6
Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations
Abstract
Background & aims: The association of Epstein-Barr virus (EBV) and gastric carcinomas (GCs) has been shown to vary among different populations and certain histological subtypes. Few studies have addressed the status of Helicobacter pylori infection and genetic alterations in these EBV-positive or -negative GCs.
Methods: Eleven gastric lymphoepithelioma-like carcinomas (LELCs) and 139 cases of common non-LELCs were evaluated for the presence of EBV DNA using polymerase chain reaction (PCR) and RNA in situ hybridization. H. pylori infection was determined by anti-H. pylori immunoglobulin G in preoperative sera. Immunostaining for p53, c-erbB-2, and E-cadherin was performed. Microsatellite instability was analyzed by PCR using 10 primers.
Results: EBV was detected in 11 (100%) LELCs and in 19 (13.7%) of 139 common GCs. Compared with EBV-negative GCs, gastric LELCs tended to have a relatively higher frequency of proximal location, diffuse histological subtype, p53 overexpression, and reduced E-cadherin expression but a lower frequency of lymph node metastasis, previous H. pylori infection, and c-erbB-2 overexpression. In contrast, no significant difference of clinicopathologic and genetic profiles was observed between EBV-positive non-LELC GCs and EBV-negative GCs. No correlation of microsatellite instability was found among these 3 subsets of GCs.
Conclusions: Dissecting clinicopathologic characteristics and infection status of EBV and H. pylori provide additional evidence of etiological and genetic heterogeneity for GC. Distinct clinicopathologic and genetic pathways exist in gastric LELCs, in which EBV may play a more important role than H. pylori infection.
Similar articles
-
Association between Helicobacter pylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas.World J Gastroenterol. 2018 Nov 21;24(43):4928-4938. doi: 10.3748/wjg.v24.i43.4928. World J Gastroenterol. 2018. PMID: 30487702 Free PMC article.
-
The Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacterpylori and/or Epstein-Barr Virus (EBV).Pol J Microbiol. 2015;64(3):211-6. Pol J Microbiol. 2015. PMID: 26638529
-
Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.Oncol Rep. 2003 Jul-Aug;10(4):1059-62. Oncol Rep. 2003. PMID: 12792770
-
Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.Arch Pathol Lab Med. 2008 Apr;132(4):706-9. doi: 10.5858/2008-132-706-EVLGC. Arch Pathol Lab Med. 2008. PMID: 18384225 Review.
-
MicroRNA Changes in Gastric Carcinogenesis: Differential Dysregulation during Helicobacter pylori and EBV Infection.Genes (Basel). 2021 Apr 19;12(4):597. doi: 10.3390/genes12040597. Genes (Basel). 2021. PMID: 33921696 Free PMC article. Review.
Cited by
-
Microsatellite instability in chicken lymphoma induced by gallid herpesvirus 2.PLoS One. 2013 Jul 2;8(7):e68058. doi: 10.1371/journal.pone.0068058. Print 2013. PLoS One. 2013. PMID: 23844155 Free PMC article.
-
Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway.Am J Pathol. 2002 Oct;161(4):1207-13. doi: 10.1016/S0002-9440(10)64397-0. Am J Pathol. 2002. PMID: 12368194 Free PMC article.
-
Inflammation-related factors predicting prognosis of gastric cancer.World J Gastroenterol. 2014 Apr 28;20(16):4586-96. doi: 10.3748/wjg.v20.i16.4586. World J Gastroenterol. 2014. PMID: 24782611 Free PMC article. Review.
-
Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.Int J Mol Sci. 2020 Dec 10;21(24):9400. doi: 10.3390/ijms21249400. Int J Mol Sci. 2020. PMID: 33321820 Free PMC article. Review.
-
The Predictive Value of Epstein-Barr Virus-Positivity in Patients Undergoing Gastrectomy Followed by Adjuvant Chemotherapy.Chonnam Med J. 2018 Sep;54(3):173-177. doi: 10.4068/cmj.2018.54.3.173. Epub 2018 Sep 27. Chonnam Med J. 2018. PMID: 30288373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous